Author:
Tamim Almohamad Almahmud,Klimov Alexey
Reference21 articles.
1. Campos, T. D., Parreira, J. G., Moricz, A. D., Rego, R. E. C., Silva, R. A., & Pacheco Junior, A. M. (2004). Fatores preditivos de coledocolitíase em doentes com litíase vesicular. Revista da Associação Médica Brasileira, 50(2), 188-194. doi: 10.1590/S0104-42302004000200037
2. Costi, R., Gnocchi, A., Di Mario, F., & Sarli, L. (2014). Diagnosis and management of choledocholithiasis in the golden age of imaging, endoscopy and laparoscopy. World Journal of Gastroenterology: WJG, 20(37), 13382-13401. doi: 10.3748/wjg.v20.i37.13382
3. Forouzesh, M., Valipour, R., Shekari, A., Barzegar, A., & Setareh, M. (2019). Comparison of Methadone Level Measurement by Enzyme Immunoassay with Gas Chromatography–Mass Spectrometry. Journal of Advanced Pharmacy Education & Research, 9(4), 105-108.
4. Huh, C. W., Jang, S. I., Lim, B. J., Kim, H. W., Kim, J. K., Park, J. S., Kim, J. K., Lee, S. J., & Lee, D. K. (2016). Clinicopathological features of choledocholithiasis patients with high aminotransferase levels without cholangitis: Prospective comparative study. Medicine, 95(42). doi: 10.1097/MD.0000000000005176
5. Jones, M. W., Genova, R., & O’Rourke, M. C. (2021a). Acute Cholecystitis. Endotherapy in Biliopancreatic Diseases: ERCP Meets EUS: Two Techniques for One Vision, 509–516. https://www.ncbi.nlm.nih.gov/books/NBK459171/